Anaphylactic Reaction to Different Gonadotropin-Releasing Hormone Agonists for the Treatment of Endometriosis
article
OA: closed
CC0
AI-generated summary
This paper investigated anaphylactic reactions occurring in patients treated with various gonadotropin-releasing hormone agonists for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Anaphylactic reactions to gonadotropin-releasing hormone (GnRH) agonists are exceedingly rare, but if they occur, they can be life threatening. This case describes a 33-year-old patient with endometriosis who developed an acute allergic reaction on leuprolide (Lucrin) administration. Although skin tests with the replacement goserelin (Zoladex) were negative, usage of this medication resulted in a similar allergic reaction. This is the first case report that shows that, in case of a proven allergy to one GnRH agonist, a switch to another GnRH agonist should not be made even if allergy tests are negative for this medication.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (9)
- Systemic Hypersensitivity Reaction to Goserelin Acetate via openalex
- W2051807182 via openalex
- W2059748956 via openalex
- W2061172182 via openalex
- W2067978628 via openalex
- W2410752591 via openalex
- W2416553290 via openalex
- W2027103523 via openalex
- doi:10.1016/s0002-9629(15)41803-8 via openalex
Source provenance
- europepmc
- last seen: 2026-08-12T06:07:16.479679+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:16:54.825375+00:00
- unpaywall
- last seen: 2026-08-12T06:43:03.944938+00:00
License: CC0
· commercial use OK